Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights Into the Role of the Compass-Like Complex Publisher Pubmed



Jamali M1 ; Barar E2 ; Shi J1
Authors

Source: International Journal of Molecular Sciences Published:2024


Abstract

Pancreatic ductal adenocarcinoma (PDAC) is poised to become the second leading cause of cancer-related death by 2030, necessitating innovative therapeutic strategies. Genetic and epigenetic alterations, including those involving the COMPASS-like complex genes, have emerged as critical drivers of PDAC progression. This review explores the genetic and epigenetic landscape of PDAC, focusing on the role of the COMPASS-like complex in regulating chromatin accessibility and gene expression. Specifically, we delve into the functions of key components such as KDM6A, KMT2D, KMT2C, KMT2A, and KMT2B, highlighting their significance as potential therapeutic targets. Furthermore, we discuss the implications of these findings for developing novel treatment modalities for PDAC. © 2024 by the authors.
Related Docs
View other Related Docs
1. The Complex Role of Macrophages in Pancreatic Cancer Tumor Microenvironment: A Review on Cancer Progression and Potential Therapeutic Targets, Discover Oncology (2024)
2. Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate Through Non-Apoptotic Cell Death?, Biomedicines (2023)
3. Identification of Novel Mirnas Potentially Involved in the Pathogenesis of Adult T-Cell Leukemia/Lymphoma Using Wgcna Followed by Rt-Qpcr Test of Hub Genes, Infectious Agents and Cancer (2023)
Experts (# of related papers)
View all Related Experts
Farid Azmoudeh Ardalan (2)
Habibollah Mahmoodzadeh (2)
Other Related Docs
4. Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool, Biomolecules (2022)
5. Anti-Tumor Activity of Cediranib, a Pan-Vascular Endothelial Growth Factor Receptor Inhibitor, in Pancreatic Ductal Adenocarcinoma Cells, Cellular Oncology (2020)
6. Signal Transduction Pathway Mutations in Gastrointestinal (Gi) Cancers: A Systematic Review and Meta-Analysis, Scientific Reports (2020)
7. Extracellular Matrix Is the Main Targeted Environment in Early Stage of Pancreatic Ductal Adenocarcinoma, Gastroenterology and Hepatology from Bed to Bench (2023)
8. Association Between Micrornas and Chemoresistance in Pancreatic Cancer: Current Knowledge, New Insights, and Forthcoming Perspectives, Pathology Research and Practice (2022)
9. Transcriptomic Analysis of Laser-Capture Microdissected Tumors Reveals Rad51ap1 As a Tumor-Specific Marker Associated Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Cancer, Cancer Cell International (2025)
10. Stage Analysis of Pancreatic Ductal Adenocarcinoma Via Network Analysis, Gastroenterology and Hepatology from Bed to Bench (2024)
11. Mir-608 Regulating the Expression of Ribonucleotide Reductase M1 and Cytidine Deaminase Is Repressed Through Induced Gemcitabine Chemoresistance in Pancreatic Cancer Cells, Cancer Chemotherapy and Pharmacology (2017)
12. Melatonin for Gastric Cancer Treatment: Where Do We Stand?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
13. Emerging Role of Enhancer Rnas As Potential Diagnostic and Prognostic Biomarkers in Cancer, Non-coding RNA (2022)
14. Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review, Health Science Reports (2025)
15. Rna-Sequencing for Transcriptional Profiling of Whole Blood in Early Stage and Metastatic Pancreatic Cancer Patients, Cell Biology International (2023)
16. Kras Mutations in Colorectal Cancer: Impacts on Tumor Microenvironment and Therapeutic Implications, Expert Opinion on Therapeutic Targets (2025)
17. Investigation of Key Signaling Pathways and Appropriate Diagnostic Biomarkers Selection Between Non-Invasive to Invasive Stages in Pancreatic Cancer: A Computational Observation, Journal of Medicine and Life (2022)
18. Pge2-Ep2/Ep4 Signaling Elicits Mesocar T Cell Immunosuppression in Pancreatic Cancer, Frontiers in Immunology (2023)
19. Abrogation of Histone Deacetylases (Hdacs) Decreases Survival of Chronic Myeloid Leukemia Cells: New Insight Into Attenuating Effects of the Pi3k/C-Myc Axis on Panobinostat Cytotoxicity, Cell Biology International (2021)
20. The Critical Role of Circular Rnas in Drug Resistance in Gastrointestinal Cancers, Medical Oncology (2023)